Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer

被引：32
|
作者：
Gemer, O [1 ]
Segal, S [1 ]
Kopmar, A [1 ]
机构：
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Med Ctr, Dept Obstet & Gynecol, IL-78306 Ashkelon, Israel
来源：
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA | 2001年 / 80卷 / 06期
关键词：
CA; 125; cytoreduction; ovarian cancer;
D O I：
10.1034/j.1600-0412.2001.080006583.x
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Background. Suboptimal cytoreduction of advanced ovarian cancer is related to initial tumor bulk which correlates with CA125 level. Methods. Retrospective record study of 40 patients with stage III ovarian cancer. The ability of a CA125 threshold level of 500 U/mL to predict suboptimal cytoreduction was determined. Results. Twenty-four (60%) of the patients were optimally cytoreduced. At the CA125 cut off level of 500 U/mL the sensitivity for predicting suboptimal debulking was 62% and specificity was 83%. Above a CA 125 level of 1500 U/mL none of the patients were optimally cytoreduced. Conclusions. More data are needed to determine the CA125 cut off level at which the standard approach of initial laparotomy and cytoreduction may be modified.
引用
收藏
页码：583 / 585
页数：3
相关论文
共 50 条
  • [1] Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer
    Merlo, Sebastjan
    Besic, Nikola
    Drmota, Eva
    Kovacevic, Nina
    RADIOLOGY AND ONCOLOGY, 2021, 55 (03) : 341 - 346
  • [2] Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level
    Obeidat, B
    Latimer, J
    Crawford, R
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2004, 57 (03) : 153 - 156
  • [3] A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer
    Gemer, O
    Lurian, M
    Gdalevich, M
    Kapustian, V
    Piura, E
    Schneider, D
    Lavie, O
    Levy, T
    Fishman, A
    Dgani, R
    Levavi, H
    Beller, U
    EJSO, 2005, 31 (09): : 1006 - 1010
  • [4] CA-125 levels as a predictor for optimal cytoreductive surgery in epithelial ovarian cancer
    Modesto Trevino-Salinas, Emilio
    Ayuzo-del Valle, Cipatli
    de Jesus del Angel-Cervantes, Julio
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (04): : 203 - 206
  • [5] Preoperative prediction of optimal resectability in advanced ovarian cancer using CA-125
    Berek, JS
    GYNECOLOGIC ONCOLOGY, 2000, 77 (02) : 225 - 226
  • [6] Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study
    Vorgias, George
    Iavazzo, Christos
    Savvopoulos, Panagiotis
    Myriokefalitaki, Eva
    Katsoulis, Michael
    Kalinoglou, Nickolas
    Akrivos, Thrassivoulos
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 11 - 15
  • [7] CA-125 AUC as a predictor for epithelial ovarian cancer relapse
    Manoa, Antonio
    Falcao, Amilcar
    Godinho, Isabel
    Santos, Jorge
    Leitao, Fatima
    de Oliveira, Carlos
    Caramona, Margarida
    CANCER BIOMARKERS, 2008, 4 (02) : 73 - 81
  • [8] Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer
    Kang, Sokbom
    Kim, Tae-Joong
    Seo, Sang-Soo
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Park, Sang-Yoon
    GYNECOLOGIC ONCOLOGY, 2011, 120 (01) : 18 - 22
  • [9] The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma
    Chi, DS
    Venkatraman, ES
    Masson, V
    Hoskins, WJ
    GYNECOLOGIC ONCOLOGY, 2000, 77 (02) : 227 - 231
  • [10] CA-125 level preoperative assessment in early and advanced ovarian carcinoma
    Raspollini, Maria Rosaria
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 356 - 357
12345